Literature DB >> 59014

Aspirin and congenital malformations.

D Slone, V Siskind, O P Heinonen, R R Monson, D W Kaufman, S Shapiro.   

Abstract

In a cohort of 50 282 gravidas and their offspring in the U.S.A., malformation rates were similar in the children of 35 418 women not exposed to aspirin, 9736 with intermediate exposure, and 5128 women heavily exposed during the first four lunar months of pregnancy. After controlling a wide range of potential confounding factors using multi-variate analysis, the observed and expected numbers for a variety of malformation categories were similar in all three comparison groups. The data suggest that aspirin is not teratogenic.

Entities:  

Keywords:  Americas; Analgesia; Cardiovascular Effects; Central Nervous System Effects; Cohort Analysis; Congenital Abnormalities; Data Analysis; Developed Countries; Diseases; Drugs; Gastrointestinal Effects; Incidence; Measurement; Multivariate Analysis; Neonatal Diseases And Abnormalities; North America; Northern America; Prospective Studies; Research Methodology; Statistical Studies; Studies; Treatment; United States; Urogenital Effects

Mesh:

Substances:

Year:  1976        PMID: 59014     DOI: 10.1016/s0140-6736(76)93025-7

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  23 in total

1.  Management of rheumatoid arthritis.

Authors:  S Carette
Journal:  Can Fam Physician       Date:  1984-06       Impact factor: 3.275

2.  Case-control analysis of maternal prenatal analgesic use and cardiovascular malformations: Baltimore-Washington Infant Study.

Authors:  Courtney A Marsh; Janet D Cragan; C J Alverson; Adolfo Correa
Journal:  Am J Obstet Gynecol       Date:  2014-03-27       Impact factor: 8.661

Review 3.  Environmental teratogens.

Authors:  R L Brent; D A Beckman
Journal:  Bull N Y Acad Med       Date:  1990 Mar-Apr

4.  Prospective survey of use of therapeutic drugs, alcohol, and cigarettes during pregnancy.

Authors:  P C Rubin; G F Craig; K Gavin; D Sumner
Journal:  Br Med J (Clin Res Ed)       Date:  1986-01-11

5.  Treatment of rheumatic diseases.

Authors:  M A Byron
Journal:  Br Med J (Clin Res Ed)       Date:  1987-01-24

Review 6.  Rheumatoid arthritis and pregnancy: safety considerations in pharmacological management.

Authors:  Ashima Makol; Kerry Wright; Shreyasee Amin
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

7.  Nonsteroidal anti-inflammatory agents in the primary treatment of rheumatoid arthritis.

Authors:  T P Anastassiades; I L Dwosh; P M Ford; G S Marks
Journal:  Can Med Assoc J       Date:  1979-10-20       Impact factor: 8.262

Review 8.  Treatment of inflammatory rheumatic disorders in pregnancy: what are the safest treatment options?

Authors:  M Ostensen; R Ramsey-Goldman
Journal:  Drug Saf       Date:  1998-11       Impact factor: 5.606

Review 9.  Aspirin and related derivatives of salicylic acid.

Authors:  S P Clissold
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 10.  Non-narcotic analgesics. Use in pregnancy and fetal and perinatal effects.

Authors:  M A Heymann
Journal:  Drugs       Date:  1986       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.